A detailed history of Vanguard Group Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,970,293 shares of ANNX stock, worth $27.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,970,293
Previous 4,556,640 9.08%
Holding current value
$27.1 Million
Previous $22.3 Million 31.79%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.49 - $7.2 $1.86 Million - $2.98 Million
413,653 Added 9.08%
4,970,293 $29.4 Million
Q2 2024

Aug 13, 2024

BUY
$4.33 - $6.79 $3.5 Million - $5.49 Million
808,985 Added 21.59%
4,556,640 $22.3 Million
Q1 2024

May 10, 2024

BUY
$4.03 - $7.81 $7.41 Million - $14.4 Million
1,839,329 Added 96.38%
3,747,655 $26.9 Million
Q4 2023

Feb 14, 2024

BUY
$1.63 - $4.63 $22,684 - $64,435
13,917 Added 0.73%
1,908,326 $8.66 Million
Q3 2023

Nov 14, 2023

BUY
$2.13 - $3.84 $308,081 - $555,413
144,639 Added 8.27%
1,894,409 $4.47 Million
Q2 2023

Aug 14, 2023

BUY
$2.1 - $6.37 $377,577 - $1.15 Million
179,799 Added 11.45%
1,749,770 $6.16 Million
Q1 2023

May 15, 2023

BUY
$3.74 - $7.46 $78,914 - $157,406
21,100 Added 1.36%
1,569,971 $6.04 Million
Q4 2022

Feb 10, 2023

BUY
$4.56 - $6.61 $38,322 - $55,550
8,404 Added 0.55%
1,548,871 $8.01 Million
Q3 2022

Nov 14, 2022

BUY
$3.75 - $6.63 $904,773 - $1.6 Million
241,273 Added 18.57%
1,540,467 $9.52 Million
Q2 2022

Aug 12, 2022

BUY
$2.11 - $4.06 $430,781 - $828,897
204,162 Added 18.64%
1,299,194 $4.9 Million
Q1 2022

May 13, 2022

BUY
$2.73 - $11.94 $53,841 - $235,480
19,722 Added 1.83%
1,095,032 $2.99 Million
Q4 2021

Feb 14, 2022

BUY
$11.49 - $22.0 $625,653 - $1.2 Million
54,452 Added 5.33%
1,075,310 $12.4 Million
Q3 2021

Nov 12, 2021

BUY
$16.35 - $23.4 $1.93 Million - $2.76 Million
117,921 Added 13.06%
1,020,858 $19 Million
Q2 2021

Aug 13, 2021

BUY
$17.81 - $27.48 $16.1 Million - $24.8 Million
902,937 New
902,937 $20.3 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $260M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.